Posts in category Healthcare


This Analyst Sees 200% Upside for Synergy Pharmaceuticals Inc (SGYP)

In a research report released Thursday, Cantor analyst William Tanner initiated coverage on shares of Synergy Pharmaceuticals …

Read more

H.C. Wainwright Initiates Buy on ZIOPHARM Oncology Inc. (ZIOP); Sees 53% Upside for the Stock

In a research report released Thursday, H.C. Wainwright analyst Swayampakula Ramakanth initiated coverage on shares of ZIOPHARM …

Read more

Roth Capital Bullish on EXACT Sciences Corporation (EXAS) as UNH Adds Cologuard to Its Commercial Coverage Guidelines

EXACT Sciences Corporation (NASDAQ:EXAS) shares rose over 10% in Wednesday’s trading session, following the news …

Read more

Gilead Sciences, Inc.’s (GILD) Bictegravir Hits Four Bull’s Eyes in HIV, Synergy Pharmaceuticals Inc’s (SGYP) Trulance Continues to Outperform Expectations

Analysts from J.P. Morgan and BTIG are coming out with bullish casts of the dice …

Read more

Protagonist Therapeutics Inc (PTGX) Skyrockets, BMO Boosts Price Target; Here’s Why

It’s a very rewarding trading day for investors in Protagonist Therapeutics Inc (NASDAQ:PTGX) with shares …

Read more

Gilead Sciences, Inc. (GILD) Positioned to Regain Share in HIV Market: Cowen

Gilead Sciences, Inc. (NASDAQ:GILD) impressed Cowen analyst Phil Nadeau with its successful four Phase III …

Read more

Analysts Boost Price Targets on Inovio Pharmaceuticals Inc (INO) Following Positive Data for HIV Vaccine

On Wednesday, Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that its HIV vaccine, PENNVAX-GP, had produced an antibody (humoral) …

Read more

Rexahn Pharmaceuticals, Inc. (RNN) Challenged with Financing Overhang; FBR Slashed Price Target

FBR analyst Vernon Bernardino, one of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) biggest bulls, is slashing the …

Read more

Oppenheimer Sees 232% Upside for MEI Pharma Inc (MEIP); Here’s Why

Oppenheimer analyst Leah R. Cann initiated coverage on shares of MEI Pharma Inc (NASDAQ:MEIP) with an …

Read more

Aerie Pharmaceuticals Inc (AERI) Moves a Step Closer to Glaucoma Drug

After market close yesterday, Aerie Pharmaceuticals Inc (NASDAQ:AERI) announced positive 3-month top-line efficacy results from …

Read more